Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Transcatheter Pulmonary Valve Market: By Technology: Balloon-Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve; By End-Use; By Application; By Raw Material; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Transcatheter Pulmonary Valve Market Outlook

The global transcatheter pulmonary valve market is expected to grow at a CAGR of 7.4% during the period 2022-2027.

 

The Global Transcatheter Pulmonary Valve Market Likely to be Driven by Advancements in Technology Enabling Easier Implants, Growing Population with Obesity and Conditions Requiring Transcatheter Pulmonary Valve Replacement, and Growing Demand for Less Invasive Procedures

Congenital heart disease affecting the right ventricle outflow tract frequently necessitates surgery and a right ventricle-pulmonary artery (RV-PA) conduit at a young age. These conduits require numerous surgical revisions due to deterioration and increased pulmonary regurgitation and/or stenosis, resulting in considerable morbidity and mortality. Furthermore, unrestricted pulmonary regurgitation causes right ventricular dilation, failure, and arrhythmias.

 

Global Transcatheter Pulmonary Valve Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Bonhoeffer et al. performed the first transcatheter pulmonary valve replacement (TPVR) in 2000, and it is currently an approved treatment for severe pulmonary regurgitation/stenosis and RV-PA conduit failure. The three balloon-expandable valves utilised for malfunctioning RV-PA conduits are the Medtronic Melody valve, Edwards SAPIEN valve, and Meril Myval.

Medtronic, the world's leading medical device business, has developed various transcatheter valve therapies. Medtronic has strategically positioned itself to dominate the transcatheter pulmonary valve (TPV) industry, but an examination of the company's performance over the last five years reveals that its US revenues in this area have remained flat. This is probable because pulmonary regurgitation (PR) is frequently asymptomatic. Historically, PR has been addressed symptomatically, with valve repair or replacement used only as a last resort.

SAPIEN 3, the latest generation of balloon-expandable transcatheter heart valves, is designed to overcome certain limitations of previous generation transcatheter heart valves. It has a reduced device profile to prevent access-related vascular damage, a more accurate delivery catheter aimed at accurate implantation, and an extra outer sealing cuff to limit paravalvular leakage. Recent European and North American trials using SAPIEN 3 have demonstrated extremely low rates of vascular complications and paravalvular regurgitation, as well as lower rates of stroke and mortality, than would be expected with surgical aortic valve replacement (SAVR) in patients with moderate to high surgical risk.

Clearly, firms are striving to offer increasingly sophisticated and efficient TPVs through advancements in technology.

Numerous people with congenital heart disease have pulmonary valve issues, either since birth or following cardiac surgery. A valve replacement may be recommended in many cases. Until the previous decade, the only way to replace a damaged pulmonary valve was through open heart surgery. Because all surgically implanted valves have a limited life expectancy, patients faced many procedures to replace the pulmonary valve over the course of their lives. Percutaneous, non-surgical pulmonary valve replacement has transformed the lives of such patients.

Patients with Tetralogy of Fallot who have previously undergone surgery but now have a leaky or constricted pulmonary valve, particularly those who have previously undergone surgical replacement, may benefit from a transcatheter pulmonary valve. Others benefitting could include patients with other underlying diagnoses who also have a non-functioning surgically implanted pulmonary valve (such as a homograft or a bioprosthetic valve); these patients include those with truncus arteriosus, aortic valve disease, who have undergone a Ross procedure, and some patients with pulmonary stenosis or atresia. The goals of transcatheter pulmonary valve replacement are to replace the pulmonary valve without surgery and to minimise the number of cardiac procedures required over a patient's lifetime.

Advancements in technology that enable easier implants, growing population with obesity and conditions that may require transcatheter pulmonary valve replacement, and growing demand for less invasive procedures are expected to drive the global transcatheter pulmonary valve market. USA and Europe are expected to be key markets.

In 2021, doctors from The Department of Cardiology, PGIMER, performed a successful transcatheter pulmonary valve replacement for the first time in North India. However, transcatheter pulmonary valve replacement remains a costly alternative and in countries like India, many people might be unable to afford the treatment.

 

Global Transcatheter Pulmonary Valve Market Segmentation

By technology, the market is classified as follows:

  • Balloon-Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

By end-use, the market is segmented into:

  • Adult
  • Pediatric

By application, the market is divided as follows:

  • Cardiac Anomaly
  • Pulmonary Atresia
  • Pulmonary Stenosis
  • Pulmonary Regurgitation
  • Tetralogy of Fallot
  • Truncus Arteriosus
  • Others

By raw material, the market is segmented into:

  • Synthetic
  • Tissue Engineered

By region, the market is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Key Industry Players in the Global Transcatheter Pulmonary Valve Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Boston Scientific Corporation
  • Direct Flow Medical, Inc.
  • Edward Lifesciences Corporation
  • Medtronic plc
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical
and Forecast Market Analysis by Segment- Technology, End-Use, Application, Raw Material, Region
Breakup by Technology Balloon-Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve
Breakup by End-Use Adult, Pediatric
Breakup by Application Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, Tetralogy of Fallot, Truncus Arteriosus, Others 
Breakup by Raw Material Synthetic, Tissue Engineered
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Boston Scientific Corporation, Direct Flow Medical, Inc., Edward Lifesciences Corporation, Medtronic plc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface          
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Transcatheter Pulmonary Valve Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Transcatheter Pulmonary Valve Historical Market (2017-2021) 
    8.3    Global Transcatheter Pulmonary Valve Market Forecast (2022-2027)
    8.4    Global Transcatheter Pulmonary Valve Market by Technology
        8.4.1    Balloon-Expanded Transcatheter Valve
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Self-Expanded Transcatheter Valve
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Transcatheter Pulmonary Valve Market by End-Use
        8.5.1    Adult
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Pediatric
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Transcatheter Pulmonary Valve Market by Application
        8.6.1    Cardiac Anomaly
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Pulmonary Atresia
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Pulmonary Stenosis
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Pulmonary Regurgitation
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Tetralogy of Fallot
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
        8.6.6    Truncus Arteriosus 
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2017-2021)
            8.6.6.3    Forecast Trend (2022-2027)
        8.6.7    Others 
    8.7    Global Transcatheter Pulmonary Valve Market by Raw Material
        8.7.1    Synthetic
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Tissue Engineered
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
    8.8    Global Transcatheter Pulmonary Valve Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
11    Value Chain Analysis 
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Boston Scientific Corporation
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Direct Flow Medical, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Edward Lifesciences Corporation
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Medtronic plc
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Others
13    Industry Events and Developments

 

List of Key Figures and Tables
 
1.    Global Transcatheter Pulmonary Valve Market: Key Industry Highlights, 2017 and 2027 
2.    Global Transcatheter Pulmonary Valve Historical Market: Breakup by Technology (USD Million), 2017-2021
3.    Global Transcatheter Pulmonary Valve Market Forecast: Breakup by Technology (USD Million), 2022-2027
4.    Global Transcatheter Pulmonary Valve Historical Market: Breakup by End-Use (USD Million), 2017-2021
5.    Global Transcatheter Pulmonary Valve Market Forecast: Breakup by End-Use (USD Million), 2022-2027
6.    Global Transcatheter Pulmonary Valve Historical Market: Breakup by Application (USD Million), 2017-2021
7.    Global Transcatheter Pulmonary Valve Market Forecast: Breakup by Application (USD Million), 2022-2027
8.    Global Transcatheter Pulmonary Valve Historical Market: Breakup by Raw Material (USD Million), 2017-2021
9.    Global Transcatheter Pulmonary Valve Market Forecast: Breakup by Raw Material (USD Million), 2022-2027
10.    Global Transcatheter Pulmonary Valve Historical Market: Breakup by Region (USD Million), 2017-2021
11.    Global Transcatheter Pulmonary Valve Market Forecast: Breakup by Region (USD Million), 2022-2027
12.    North America Transcatheter Pulmonary Valve Historical Market: Breakup by Country (USD Million), 2017-2021
13.    North America Transcatheter Pulmonary Valve Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Europe Transcatheter Pulmonary Valve Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Europe Transcatheter Pulmonary Valve Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Asia Pacific Transcatheter Pulmonary Valve Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Asia Pacific Transcatheter Pulmonary Valve Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Latin America Transcatheter Pulmonary Valve Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Latin America Transcatheter Pulmonary Valve Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Middle East and Africa Transcatheter Pulmonary Valve Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Middle East and Africa Transcatheter Pulmonary Valve Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Global Transcatheter Pulmonary Valve Market Structure

Key Questions Answered in the Report

The market is estimated to grow at a CAGR of 7.4% between 2022 and 2027.

The major drivers of the market include the rising healthcare expenditure, rising health awareness, increasing cases of obesity and conditions requiring transcatheter pulmonary valve replacement, and rapid development of advanced transcatheter by major market players.

The increasing inclination towards minimally invasive treatment procedures and rapid advancements in technology enabling easier implants are expected to be the key trends guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Based on technology, the market can be segmented into balloon-expanded transcatheter valve and self-expanded transcatheter valve.

Adult and pediatric are the major end-users considered in the report.

Cardiac anomaly, pulmonary atresia, pulmonary stenosis, pulmonary regurgitation, tetralogy of fallot, and truncus arteriosus, among others are the major applications mentioned in the market report.

Synthetic and tissue engineered are the different raw materials on the basis of which the market has been bifurcated.

The major players in the industry are Boston Scientific Corporation, Direct Flow Medical, Inc., Edward Lifesciences Corporation, and Medtronic plc, among others.

Analyst Review

The global transcatheter pulmonary valve market is being driven by the rising healthcare expenditure, and the increasing preference towards minimally invasive surgeries. Aided by the growing R&D activities by the major healthcare players to develop advanced implant technology, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 7.4%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on technology, the market is divided into balloon-expanded transcatheter valve and self-expanded transcatheter valve. On the basis of end-user, the market is divided into adult and pediatric. The significant applications of the product include cardiac anomaly, pulmonary atresia, pulmonary stenosis, pulmonary regurgitation, tetralogy of fallot, and truncus arteriosus, among others. By raw material, the market has been bifurcated into synthetic and tissue engineered. The major regional markets for transcatheter pulmonary valve are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Boston Scientific Corporation, Direct Flow Medical, Inc., Edward Lifesciences Corporation, and Medtronic plc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER